Skip to main content

Table 2 Clinical outcomes and hemodynamics, baseline and change during follow-up

From: Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries

Parameter

Baseline

Follow-up

 

N*

Mean ± SD

N*

Δ during observation (Mean ± SD)

6 MWD, meters

92

298 ± 120

90

30 ± 90

Pulmonary atrial pressure (PAP),mmHg

107

45.5 ± 0.6

51

−2.5 ± 13.4

Pulmonary capillary wedge pressure, mm Hg

98

9.5 ± 4.6

43

−1.0 ± 5.9

Right atrial pressure (RAP), mmHg

96

8.1 ± 5.8

53

−0.43 ± 6.7

Pulmonary vascular resistance (PVR), dyn × sec × cm−5

94

797 ± 416

37

−111 ± 360

Cardiac index, l/min/m2

98

2.2 ± 0.5

49

1.11 ± 3.3

Borg dyspnoea index

81

4.7 ± 2.2

78

−0.5 ± 2.7

FEV1, litres

86

2.0 ± 0.7

71

−0.1 ± 0.3

FEV1/vital capacity

87

71.5 ± 12.3

72

−3.1 ± 10.4

  1. *Sample size may vary due to missing values in the patient records.
  2. FEV1, Forced Expiratory Volume in 1 second; 6-MWD, walking distance in 6 minutes.